Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2009-02-26
2010-11-09
Oh, Taylor Victor (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C562S442000
Reexamination Certificate
active
07829594
ABSTRACT:
Novel calcilytic compounds and methods of using them are provided.
REFERENCES:
patent: 4212877 (1980-07-01), Köppe et al.
patent: 4229449 (1980-10-01), Melloni et al.
patent: 4234595 (1980-11-01), Kreighbaum et al.
patent: 4255430 (1981-03-01), Köppe et al.
patent: 4256756 (1981-03-01), Köppe et al.
patent: 4381309 (1983-04-01), Köppe et al.
patent: 4495352 (1985-01-01), Kreighbaum et al.
patent: 4767784 (1988-08-01), Zölss et al.
patent: 4806655 (1989-02-01), Wagnon et al.
patent: 6022894 (2000-02-01), Delmar et al.
patent: 6291459 (2001-09-01), Bhatnagar et al.
patent: 6294531 (2001-09-01), Barmore et al.
patent: 6335338 (2002-01-01), Bhatnagar et al.
patent: 6395919 (2002-05-01), Bhatnagar et al.
patent: 6417215 (2002-07-01), Lago
patent: 6432656 (2002-08-01), Del Mar et al.
patent: 6521667 (2003-02-01), Del Mar et al.
patent: 6818660 (2004-11-01), Del Mar et al.
patent: 6864267 (2005-03-01), Bhatnagar et al.
patent: 6890955 (2005-05-01), Hadri et al.
patent: 7109238 (2006-09-01), Lago et al.
patent: 7202261 (2007-04-01), Del Mar et al.
patent: 2002/0019440 (2002-02-01), Philippe et al.
patent: 2007/0010571 (2007-01-01), Garvey et al.
patent: 2007/0197555 (2007-08-01), Shcherbakova et al.
patent: 2007/0203226 (2007-08-01), Marquis
patent: 4040186 (1991-06-01), None
patent: 298506 (1992-09-01), None
patent: 442062 (1977-04-01), None
patent: 480066 (1980-04-01), None
patent: 421076 (1986-04-01), None
patent: 2014981 (1979-09-01), None
patent: WO 97/31640 (1997-09-01), None
patent: WO 97/37967 (1997-10-01), None
patent: WO 98/44925 (1998-10-01), None
patent: WO 99/51241 (1999-10-01), None
patent: WO 01/07026 (2001-02-01), None
patent: WO 01/08673 (2001-02-01), None
patent: WO 01/53254 (2001-07-01), None
patent: WO 02/07673 (2002-01-01), None
patent: WO 02/34204 (2002-05-01), None
patent: WO 02/38106 (2002-05-01), None
patent: WO 02/072760 (2002-09-01), None
patent: WO 02/07673 (2003-10-01), None
patent: WO 2005/030746 (2005-04-01), None
patent: WO 2005/077892 (2005-08-01), None
patent: WO 2006/052899 (2006-05-01), None
patent: WO 2006/078995 (2006-07-01), None
CA Abstract DN 88:22352 Dr. Andreu. 1-Aryloxy-2-hydroxy-3-alkylaminopropanes. Spanish Application 442062. Apr. 1, 1977.
CA Abstract DN 85:142815 Dr. Andreu. 1-Aryloxy-3-(aralkylamino)-2-propanols. Spanish Application 421076. Apr. 1, 1986.
CA Abstract DN 117:7640 Bercher, H. and Grisk, S. (to Ernst-Moritz-Arndt Univ.) Process for the preparation of 1-(dihalophenoxy)-3-[(1,1-dimethyl-2-phenylethyl)amino]-2- propanols and their use as β-adrenergic agaonists or antagonists. German (DDR) Patent 298506. Feb. 27, 1992.
Castedo et al., “Bloqueantes β-Adrenergicos: Sintesis Del (R)-1-[(1,1-Dimetil-2-Feniletil)Amino]-3-(3,4-Dichlorofenox])-2-Propanol”,Anales De Quimica, vol. 80, No. 3, pp. 291-294 (1984) (Spanish).
F. Espinosa and A. Paniello,Anales De Quimica, vol. 77, No. 1, pp. 22-27 (1981) (Spanish).
Abstract 91-194494/27 (Derwent Information Ltd.) Geisen et al. Use of 3-amino-propan-1,2-di:ol derivatives as racemate, Enantiomeric mixture of pure enantiomer in treatment of diabetes melliltus. German Patent DE 40 40 186 A1. Jun. 27, 1991.
Kreighbaum et al., “Antihypertensive Indole Derivatives of Phenoxypropanolamines with β-Adrenergic Receptor Antagonist and Vasodilating Activity”,J. Med. Chem, vol. 23, No. 3, pp. 285-289 (1980).
B. Law and L. Stafford,Journal of Pharmaceutical&Biomedical Analysis, vol. II, No. 8, pp. 729-736 (1993).
CA Abstract DN 93:167911 Montoro, F. et al. [to Especialidades Latinas Medicamentos Universales) 1-(4-Chloro-α,α-dibenzomethylbenzenoethanamino)-2-hydroxy-3-(aryloxy)propanes. Spanish Application 480066. Apr. 1, 1980.
Shuker et al., “The Application of High-Throughput Synthesis and Purification to the Preparation of Ethanolamines”,Tetrahedron Letters, vol. 38, No. 35, pp. 6149-6152 (1997).
CA Abstract DN 93:167911 Montoro, F. et al. [to Especialidades Latinas Medicamentos Universales) 1-(4-Chloro-α,α-dibenzomethylbenzenoethanamino)-2-hydroxy-3-(aryloxy)propanes. Spanish Application 480066. Apr. 1, 1980.
U.S. Appl. No. 10/587,771, Marquis et al., Calcilytic Compounds, filed Feb. 4, 2005, published Aug. 25, 2005 (see WO 2005/077892 A1).
Callahan James Francis
Casillas Linda N.
Marquis Robert W.
Ramanjulu Joshi M.
GlaxoSmithKline LLC
Kinzig Charles M.
Oh Taylor Victor
Sauermelch Loretta J.
Scrivner Alan
LandOfFree
Calcilytic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcilytic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcilytic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4174425